Peptone
peptone.io
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Peptone applies machine learning and physics simulation to intrinsically disordered proteins, a class long considered undruggable. Founded in 2017 and headquartered in Switzerland with laboratories in the United Kingdom, it combines biophysics experiments with learned models. Its pipeline targets neurodegeneration and oncology.
News
Peptone Hosts In-Person Advisory Meeting With Leading Experts in Oncology, Drug Development and Medicinal Chemistry to Advance Small Molecule IDP-Targeted Treatment Solutions
Peptone, a biotech company developing novel therapeutics targeting intrinsically disordered proteins (IDPs) to treat diseases, successfully convened its H1 Advisory Board meeting this past week, uniting leading pharmaceutical and biomedical research exper
Read more
Report
Peptone: finding opportunity in disorder
Combining experimental and computational tools, this company is targeting disordered regions of proteins previously thought to be undruggable.
Read more
Report
How plant peptones are emerging as a sustainable organic nitrogen source for fermentation and cell culture media
Peptone is the product of moderate hydrolysis of protein, rich in peptides and amino acids, which provides nitrogen source for the growth of microorganisms and animal cells, as well as trace elements and growth factor
Read more
Report
Pro access
Upgrade to see all 13 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.